Lantus Dose Adjustment for Overnight Blood Glucose of 140 mg/dL

Assessment of Current Glycemic Control

An overnight blood glucose of 140 mg/dL is considered within target range for hospitalized patients according to multiple clinical guidelines, including the American Diabetes Association and American Association of Clinical Endocrinologists, which recommend a target glucose range of 140-180 mg/dL for most hospitalized patients 1, 3, 4, 5
The American Diabetes Association recommends a target glucose range of 140-180 mg/dL for most hospitalized patients, with pre-meal glucose targets of <140 mg/dL and random blood glucose targets of <180 mg/dL for non-critically ill patients 4, 5

The current blood glucose reading of 140 mg/dL represents the lower boundary of the recommended target range, indicating adequate glycemic control, and attempting to lower blood glucose below 140 mg/dL increases the risk of hypoglycemia without providing additional clinical benefit 2, 3, 5, 6
The NICE-SUGAR trial demonstrated increased mortality with intensive insulin therapy targeting lower glucose values, supporting the 140-180 mg/dL target range 3

Continue to monitor blood glucose regularly to ensure values remain within the 140-180 mg/dL target range, and if blood glucose consistently falls below 140 mg/dL, consider reducing the Lantus dose by 10-20% (2-5 units) to prevent hypoglycemia 2, 5, 6

Avoid aggressive titration aiming for "normal" blood glucose levels (<140 mg/dL), as this increases hypoglycemia risk without improving outcomes, and be aware that insulin requirements may change with alterations in clinical status, nutritional intake, or concurrent medications (especially corticosteroids) 3, 5, 6
Elderly patients have increased risk of hypoglycemia and may benefit from less stringent glycemic targets (up to 180-200 mg/dL), and point-of-care glucose testing may be less accurate in critically ill patients or those with anemia, potentially affecting treatment decisions 3, 6